FDA Device Center Working Out “Nuts And Bolts” Of Interactive Review
This article was originally published in The Gray Sheet
Executive Summary
If all goes as planned, beginning Oct. 1 FDA device reviewers will be taking a new, more interactive approach to product applications, though agency officials are still unsure exactly how the method will work
You may also be interested in...
New Interactive FDA Device Review Is Significant, But Goes Only So Far
An FDA staffer trying to create an informal, "interactive review" process for devices warned companies last week that even under the new system they should not expect extensive discussion without temporarily halting review of an application
New Interactive FDA Device Review Is Significant, But Goes Only So Far
An FDA staffer trying to create an informal, "interactive review" process for devices warned companies last week that even under the new system they should not expect extensive discussion without temporarily halting review of an application
Congress Approves FDA Reform/User Fee Bill In The Nick Of Time
Congress gave final approval last week to a massive FDA bill that renews device and drug user fees for five years and strengthens product safety programs